On Tuesday, the FDA delivered words of extreme caution to 14 companies based in the U.S. who they allege illicitly sold over 65 medications deceitfully disguised as Cancer Treatments. The suspected organizations sold the fraudulent products without any endorsements from the U.S. Food and Drug Administration. They promoted the drugs on several web pages and social platforms that remain undisclosed. In a statement released on their website this week, the FDA informed consumers not to utilize the deceptive products or items they purchased from these companies that are similar in equivalence.

The government entity notes that the medications have the potential to be hazardous and could inhibit cancer patients from receiving proper treatments and diagnosis.

Stearn warns the public

Douglas W. Stearn, Chief Officer of the FDA’s Department of Regulatory Affairs, mentioned in the press release that the agency urges the American population to be more careful both in-store and on the web with their purchases. He noted that the FDA requests for consumers to abstain from medications advertised to treat any malignancy with no substantial evidence confirming that the product works. Stearn further suggested that patients seek their primary care physicians if they wish to know more about their options in proper cancer treatment, diagnosis, and prevention.

According to the FDA, the 14 companies in question infringed upon the U.S. Food, Drug, and Cosmetic Act. The federal law states that it is highly illegal to promote and sell medications that claim to counteract, analyze, treat, relieve or cure illnesses without first exhibiting to the FDA that their labeled uses are both safe and efficient.

The items mentioned in the letter included pills, topical creams, salves, oils, drops, syrups, teas, and diagnostics. Not only did the corporations sell the drugs illegally, they marketed the medications for use on both humans and animals without providing proper evidence of using the drugs in cancer treatments.

The government expects company action

The FDA demands immediate responses from the companies who sold the drugs expressing how they plan to remedy their infringements. Their inability to amend those violations in a timely manner may bring about lawful activity, including item seizure, penalty, fees, and eventually criminal arraignment.

The FDA issued over 90 letters within the past decade to numerous organizations advertising fraudulent drugs as a significant aspect in their efforts to shield American consumers from extortion. Most of these organizations have quit offering the items, and quit making false claims. However, there are those that deliberately sell many of the same deceptive products to consumers simply by promoting their operations on new websites.

The U.S. Food and Drug Administration monitors and retaliates against corporations that market and pitch doubtful medical treatments. Their goal is to limit all possible threats to buyers, while educating consumers about the potential dangers.